The complaint alleges that SES AI Corp. and its CEO made materially false and misleading statements, overstating the Company’s business prospects, partnerships, and revenue potential. The complaint claims SES touted deals with entities that lacked meaningful operations, exaggerated the capabilities and commercialization of its “Molecular Universe” AI platform, and failed to disclose material logistics issues that negatively impacted revenue. According to the complaint, the truth began to emerge through a December 2025 short-seller report and subsequent disclosures, culminating in weak 2026 revenue guidance that fell well below expectations. Following these revelations, SES’s stock price declined significantly, causing losses to investors who purchased shares during the class period.
You may be able to recover your losses in SES AI Corp. stock.
Our attorneys have recovered billions of dollars for defrauded investors. Submit your details for a free, no-obligation case evaluation. You may be eligible to participate in this action, including as a lead plaintiff.